Updates matching "Access to Biomarker Testing"

California Governor Gavin Newsom announced he has signed Senate Bill 496, ensuring that more health insurance plans, including Medi-Cal, cover comprehensive biomarker testing when supported by medical and scientific evidence.

FORT MYERS, FL -- The most rewarding part of our roles as oncology providers is the opportunity to extend and enrich lives. It enables people to witness cherished milestones such as a child’s wedding or the birth of a grandchild. The oncology world is witnessing a transformative phase with

The California Legislature passed a bill to ensure that more health insurance plans, including Medi-Cal, cover comprehensive biomarker testing . Senate Bill 496, sponsored by ACS CAN and the University of California, now heads to the governor’s desk.

ALBANY, NY – JUNE 9, 2023 – Late last night, the New York State Assembly passed Assembly Bill 1673a to increase access to biomarker testing, which can help determine the best treatment plan for each patient. The bill will now go to Governor Hochul’s desk, providing her the opportunity to

Today, Gov. Kevin Stitt signed legislation that will improve access to care for cancer patients by expanding coverage for biomarker testing. Senate Bill 513 will enable more patients to benefit from biomarker testing, an essential step in accessing precision medicine treatments.

LAS VEGAS, NEV. – The Nevada State Legislature passed Assembly Bill 155 as the 82nd legislative session adjourned, Monday. The bill establishes provisions for biomarker testing in Nevada but falls short of ensuring broader patient access to needed testing. While the American Cancer Society Cancer Action Network (ACS CAN) appreciates lawmakers’ recognition of the growing importance of biomarker testing in the treatment of cancer and other conditions, this bill was significantly weakened from its original intent.

Gov. Greg Abbott signed legislation that will improve access to care for cancer patients and people with other conditions by expanding coverage for biomarker testing. Senate Bill 989 will enable more patients to benefit from biomarker testing, an essential step in accessing precision medicine treatments.

ALBANY, NY – JUNE 5, 2023 – This afternoon, the New York State Senate passed legislation that would ensure biomarker testing is covered by more insurance plans, including Medicaid, when patients need it. This legislative victory came several hours after the American Cancer Society Cancer Action Network (ACS CAN) hosted

AUSTIN, TX – MAY 30, 2023 – Yesterday, Texas Governor Greg Abbott signed Senate Bill 989 into law, making Texas the 11 th state to expand access to biomarker testing. New York is considering comparable legislation through Assembly Bill 1673 / Senate Bill 1196. The American Cancer Society Cancer